Home Blood Pressure Monitoring (HBPM)

What are HFimpEF, HFrecHF, and HFremEF?

by Prateek Chopra | May 14, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure phenotypes characterized by improvement or recovery in le ventricular ejec on frac on (LVEF) have emerged as important clinical en es, leading to the evolving concepts of heart failure with improved ejec on frac on (HFimpEF), heart failure with recovered heart failure (HFrecHF/HFrecEF), and heart failure […]

What are HFimpEF, HFrecHF, and HFremEF? Read Post »

Clinical Practice Update – What Should We Do Di erently Now

by Prateek Chopra | June 20, 2026 | Cardiology Conferences | ESH 2026 Study Background: Despite established guidelines, hypertension remains poorly controlled globally, particularly in primary care. Barriers to guideline implementation include structural, behavioral, and communication challenges across healthcare systems. This session outlined practical strategies to transform everyday hypertension management using insights from clinicians across Europe. Methodology & Framework: Key Insights:

Clinical Practice Update – What Should We Do Di erently Now Read Post »

The INDependent Study: First Real-World Clinical Experience with an ARB/Indapamide Single-Pill Combination

by Prateek Chopra | June 11, 2026 | Cardiology Conferences | ESH 2026 Study Focus: Evaluate the real-world effectiveness, metabolic safety, and tolerability of valsartan/indapamide single-pill combinations (SPCs) in European hypertensive patients in routine clinical practice. Study Design: Patient Population: Key Findings: The INDependent study provides the first real-world evidence that valsartan/indapamide SPC delivers marked, sustained, and well-tolerated BP control in

The INDependent Study: First Real-World Clinical Experience with an ARB/Indapamide Single-Pill Combination Read Post »

Scroll to Top